Henry W. Murray

Active 1969–2020

Also published as
HENRY W. MURRAY · Henry W Murray
86
Papers
20,345
Citations
81
h-index
86
i10-index

Citations

Citations per year for Henry W. Murray1969: 1 citations1970: 2 citations1971: 1 citations1974: 2 citations1975: 2 citations1976: 2 citations1977: 1 citations1978: 6 citations1979: 7 citations1980: 18 citations1981: 25 citations1982: 47 citations1983: 98 citations1984: 112 citations1985: 137 citations1986: 110 citations1987: 131 citations1988: 160 citations1989: 128 citations1990: 114 citations1991: 85 citations1992: 116 citations1993: 114 citations1994: 95 citations1995: 90 citations1996: 64 citations1997: 97 citations1998: 123 citations1999: 116 citations2000: 160 citations2001: 169 citations2002: 138 citations2003: 121 citations2004: 159 citations2005: 152 citations2006: 189 citations2007: 171 citations2008: 118 citations2009: 105 citations2010: 131 citations2011: 137 citations2012: 116 citations2013: 90 citations2014: 145 citations2015: 80 citations2016: 97 citations2017: 73 citations2018: 49 citations2019: 186 citations2020: 235 citations2021: 151 citations2022: 104 citations2023: 72 citations2024: 140 citations2025: 44 citations1972–1973: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,647 citing papers, 32.9% of this breakdownUnited Kingdom: 375 citing papers, 7.5% of this breakdownIndia: 329 citing papers, 6.6% of this breakdownBrazil: 243 citing papers, 4.9% of this breakdownFrance: 227 citing papers, 4.5% of this breakdownCanada: 214 citing papers, 4.3% of this breakdownGermany: 205 citing papers, 4.1% of this breakdownSwitzerland: 146 citing papers, 2.9% of this breakdownSpain: 119 citing papers, 2.4% of this breakdownAustralia: 115 citing papers, 2.3% of this breakdownItaly: 108 citing papers, 2.2% of this breakdownBelgium: 104 citing papers, 2.1% of this breakdown
0%32.9%Other 23.3%

Fields

  • Medicine64%
  • Immunology and Microbiology22%
  • Biochemistry, Genetics and Molecular Biology5.6%
  • Neuroscience2.8%
  • Agricultural and Biological Sciences2.6%
  • Nursing0.6%
  • Other2.4%

Topics

  • Research on Leishmaniasis Studies11.8%
  • Trypanosoma species research and implications7.2%
  • Immune Cell Function and Interaction3.4%
  • Parasites and Host Interactions3.2%
  • Pneumocystis jirovecii pneumonia detection and treatment2.8%
  • Immune Response and Inflammation2.2%
  • Other69.4%

Coauthors

All papers

Open in search
  1. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

    Authors: , , , - The Journal of Experimental Medicine 1983 cited by 1,958

  2. Advances in leishmaniasis

    Authors: , , , - The Lancet 2005 cited by 1,776

  3. Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India

    Authors: , , , , - New England Journal of Medicine 2010 cited by 427

  4. Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic

    Authors: , , , , , , , - Clinical Infectious Diseases 2000 cited by 651

  5. Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies

    Authors: , , , , , , , , , , , , , , , - Annals of Internal Medicine 1984 cited by 856

  6. An Outbreak of Community-AcquiredPneumocystis cariniiPneumonia

    Authors: , , , , , , , , , , - New England Journal of Medicine 1981 cited by 1,430

  7. New Treatment Approach in Indian Visceral Leishmaniasis: Single‐Dose Liposomal Amphotericin B Followed by Short‐Course Oral Miltefosine

    Authors: , , , , , , , - Clinical Infectious Diseases 2008 cited by 212

  8. Tissue granuloma structure‐function in experimental visceral leishmaniasis

    Authors: - International Journal of Experimental Pathology 2001 cited by 207

  9. Occurrence and spread of the banana fungus Fusarium oxysporum f. sp. cubense TR4 in Mozambique

    Authors: , , , , , , , , , , , , , , , , , , , - South African Journal of Science 2020 cited by 53

  10. Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as Immunotherapy

    Authors: , , , , , , - Infection and Immunity 2002 cited by 249

  11. Trial of oral miltefosine for visceral leishmaniasis

    Authors: , , , , , , , - The Lancet 1998 cited by 245

  12. Macrophage Microbicidal Mechanisms In Vivo: Reactive Nitrogen versus Oxygen Intermediates in the Killing of Intracellular Visceral Leishmania donovani

    Authors: , - The Journal of Experimental Medicine 1999 cited by 415

  13. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.

    Authors: , , - Journal of Clinical Investigation 1983 cited by 404

  14. Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.

    Authors: , , - The Journal of Immunology 1985 cited by 358

  15. Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages

    Authors: , , , , , , , - Infection and Immunity 1989 cited by 199

  16. Amphotericin B Treatment for Indian Visceral Leishmaniasis: Conventional versus Lipid Formulations

    Authors: , , , , , - Clinical Infectious Diseases 2004 cited by 188

  17. Roles of Endogenous Gamma Interferon and Macrophage Microbicidal Mechanisms in Host Response to Chemotherapy in Experimental Visceral Leishmaniasis

    Authors: , - Infection and Immunity 2000 cited by 116

  18. Visceral Leishmaniasis in Mice Devoid of Tumor Necrosis Factor and Response to Treatment

    Authors: , , , , - Infection and Immunity 2000 cited by 112

  19. Amphotericin B Treatment for Indian Visceral Leishmaniasis: Response to 15 Daily versus Alternate-Day Infusions

    Authors: , , , , , , - Clinical Infectious Diseases 2007 cited by 91

  20. Activation of human macrophages. Comparison of other cytokines with interferon-gamma.

    Authors: , , , , , , , , - The Journal of Experimental Medicine 1984 cited by 357

  21. A Subset of Liver NK T Cells Is Activated duringLeishmania donovaniInfection by CD1d-bound Lipophosphoglycan

    Authors: , , , , , , , - The Journal of Experimental Medicine 2004 cited by 202

  22. L-Arginine-Dependent Reactive Nitrogen Intermediates and the Antimicrobial Effect of Activated Human Mononuclear Phagocytes

    Authors: , - The Journal of Infectious Diseases 1992 cited by 179

  23. Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trialCommentary: cost and resistance remain issues

    Authors: , , , , , - BMJ 2001 cited by 167

  24. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.

    Authors: , , , , - The Journal of Immunology 1988 cited by 163